Skip to main content
Powered by ShareScore

Find research datasets worth reusing

Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.

302

datasets available to search

ShareScore release 0.9.0

Reset

Dataset results

302 results for “Incidence studies”

Learn how ShareScore rates datasets ↗
dryad24/100

Data from: Ectopic fat obesity presents the greatest risk for incident type 2 diabetes: a population-based longitudinal study

Objectives: Obesity is a risk factor for type 2 diabetes mellitus. Among obesity, visceral fat obesity, and ectopic fat obesity, it has been unclear which has the greatest effect on incident diabetes. Methods: In this historical cohort study of 8430 men and 7034 women, we investigated the effect of obesity phenotypes on incident diabetes. Obesity, visceral fat obesity, and ectopic fat obesity were defined as body mass index ≥25 kg/m2, waist circumference ≥90 cm in men or ≥80 cm in women, and having fatty liver diagnosed by abdominal ultrasonography, respectively. We divided the participants into eight groups according to the presence or absence of the three obesity phenotypes. Results: During the median 5.8 years follow-up for men and 5.1 years follow-up for women, 286 men and 87 women developed diabetes. Compared to the non-obese group, the hazard ratios (HRs) of incident diabetes in the only-obesity, only-visceral fat obesity, only-ectopic fat obesity groups, and with all-three types of obesity group were 1.85 (95%CI 1.06–3.26, p = 0.05) in men and 1.79 (0.24–13.21, p = 0.60) in women, 3.41 (2.51–4.64, p < 0.001) in men and 2.30 (0.87–6.05, p = 0.12) in women, 4.74 (1.91–11.70, p < 0.001) in men and 13.99 (7.23–27.09, p < 0.001) in women and 10.5 (8.02–13.8, p < 0.001) in men and 30.0 (18.0–50.0, p < 0.001) in women. Moreover, the risk of incident diabetes of the groups with ectopic fat obesity were almost higher than that of the four groups without ectopic fat obesity. Conclusion: Ectopic fat obesity presented the greatest risk of incident type 2 diabetes.

opencc-zeroDec 2017View details →
zenodo24/100

Increasing Contribution of Adolescent Type 1 Diabetes Drives Incidence Rates in Poland - a 40-year-long Observational Study

<div> <div> <p><span><span>Aims/hypothesis</span></span><span><span>: </span><span>40-year-long longitudinal observation</span> <span>of long-term trends of type 1 diabetes</span><span> incidence</span><span> and prevalence</span> <span>in children </span><span>in Central P</span><span>o</span><span>land&nbsp;</span></span><span>&nbsp;</span></p> </div> <div> <p><span><span>Methods</span></span><span><span>: This was a prospective observational study performed </span><span>by </span><span>a reference </span><span>regional </span><span>center</span><span> for pediatric diabetes care for Lodz Province (currently 2</span><span>&middot;</span><span>4M </span><span>inhabitants</span><span>, 360K children). </span><span>We </span><span>registered </span><span>e</span><span>ach case of new-onset </span><span>type 1 </span><span>diabetes </span><span>admitted</span> <span>to regional pediatric diabetes centers </span><span>between </span><span>the </span><span>years 1983 and 2022 in children between 0 and 14 </span><span>y.o.</span> <span>The diagnosis</span><span> was based on </span><span>currently </span><span>available guidelines</span><span>.</span> <span>C</span><span>ases of other types of diabetes (e.g.</span><span>,</span><span> monogenic) were excluded</span><span> upon identification from incidence and prevalence rates</span><span>. Yearly data on the at</span><span>-</span><span>risk</span> <span>population were </span><span>acquired</span><span> from Poland`s General Statistical Office. Sex-specific data </span><span>on population structure </span><span>were available from 1989 onwards.</span><span>&nbsp;</span></span><span>&nbsp;</span></p> </div> <div> <p><span><span>Results</span></span><span><span>: In the </span><span>analyzed</span> <span>period, </span><span>the </span><span>incidence rate</span><span> of type 1 diabetes</span><span> increased </span><span>tenfold </span><span>from 3</span><span>&middot;</span><span>29/100</span><span>,</span><span>000 (95%CI: </span><span>1</span><span>&middot;</span><span>85</span><span>-</span><span>4</span><span>&middot;</span><span>73</span><span>) in 1983 to 3</span><span>2.43</span><span> (2</span><span>6</span><span>&middot;</span><span>42-38</span><span>&middot;</span><span>44</span><span>) in 2022, with </span><span>an </span><span>average annual percentage change of 5</span><span>&middot;</span><span>73</span><span>% (95%CI: 4</span><span>&middot;</span><span>9</span><span>9</span><span>%-6</span><span>&middot;</span><span>44</span><span>%). Joinpoint analysis detected two distinct periods of increase</span><span>:</span> <span>rapid in 1983-200</span><span>5</span><span> (annual percentage increase </span><span>of </span><span>7</span><span>&middot;</span><span>38</span><span>%</span><span>, 95%CI: </span><span>6</span><span>&middot;</span><span>30</span><span>-1</span><span>0</span><span>&middot;</span><span>52</span><span>%</span><span>) and </span><span>a </span><span>slower </span><span>one</span><span> in </span><span>200</span><span>5</span><span>-2022 (3</span><span>&middot;</span><span>65</span><span>%</span><span>, 95%CI: -0</span><span>&middot;</span><span>86</span><span>-</span><span>5</span><span>&middot;</span><span>13</span><span>%</span><span>). </span><span>I</span><span>ncidence rates among the youngest children (0-4</span> <span>y.o.</span><span>) were significantly lower than in 5-9</span> <span>y.o.</span><span> (</span><span>&beta;&plusmn;</span><span>SE: -0</span><span>&middot;</span><span>5</span><span>67</span><span>&plusmn;</span><span>0</span><span>&middot;</span><span>059</span><span>, p&lt;0</span><span>&middot;</span><span>0001</span><span>)</span><span> and 10-14</span> <span>y.o.</span><span> (</span><span>&beta;&plusmn;</span><span>SE: -0</span><span>&middot;</span><span>520</span><span>&plusmn;</span><span>0</span><span>&middot;</span><span>0</span><span>60</span><span>, p&lt;0</span><span>&middot;</span><span>0001)</span><span>. </span><span>The </span><span>incidence </span><span>growth dynamic </span><span>for</span> <span>the two older groups showed </span><span>a </span><span>consistent </span><span>increase</span><span>, </span><span>whereas</span><span> the incidence in </span><span>0-4 year-olds</span><span> plateaued after 2007.</span> <span>Incidence rates varied </span><span>seasonally,</span><span> with the </span><span>most cases diagnosed </span><span>during the </span><span>winter months (December, January, </span><span>and </span><span>February</span><span>;</span> <span>mean difference from remaining seasons of 29</span><span>&plusmn;11</span><span>&middot;</span><span>6 percentage points</span><span>, p</span><span>&lt;0</span><span>&middot;</span><span>0001</span><span>). </span><span>Corresponding with increasing incidence rate, estimated prevalence of type 1 diabetes increased over the years and reached </span><span>177</span><span>&middot;</span><span>21</span><span>/100</span><span>,</span><span>000 (95%CI: 163</span><span>&middot;</span><span>18-191</span><span>&middot;</span><span>24)</span><span> for children 0-14 </span><span>y.o.</span><span>,</span><span> and</span><span>&nbsp;</span> <span>1</span><span>7</span><span>&middot;</span><span>11</span> <span>(95%CI:</span><span> 9</span><span>&middot;</span><span>2</span><span>-</span><span>2</span><span>5</span><span>&middot;</span><span>02</span><span>),</span><span> 1</span><span>90</span><span>&middot;</span><span>54</span><span> (95%CI:</span> <span>16</span><span>5</span><span>&middot;</span><span>03</span><span>-</span><span>21</span><span>5</span><span>&middot;</span><span>75</span><span>),</span><span> 2</span><span>38</span><span>&middot;</span><span>73</span><span> (95%CI: </span><span>21</span><span>1</span><span>&middot;</span><span>7</span><span>-26</span><span>5</span><span>&middot;</span><span>76</span><span>)</span><span> for 0-4</span><span>,</span><span> 5-9</span><span>, </span><span>and 10-14</span> <span>y.o.</span><span>, respectively.</span></span><span>&nbsp;</span></p> </div> <div> <p><span><span>Conclusion/i</span><span>nterpretation</span></span><span><span>: </span><span>Over the past 40 years, the incidence of </span><span>type 1 diabetes</span><span> in </span><span>children in </span><span>Central Poland </span><span>has increased significantly, but the rate of increase </span><span>appears to be</span><span> slowing.</span><span> As</span> <span>majority</span><span> of patients with type 1 diabetes are 10 years old or older, with the </span><span>most new</span><span> cases occurring in that age group</span><span> the healthcare systems should prepare for care of young adults who are extensive users of new diabetes technologies</span><span>.</span></span><span>&nbsp;</span></p> </div> </div>

restrictedcc-by-4.0Aug 2024View details →
ClinicalTrials.gov24/100

Study of the Incidence and Prognosis of Intrahospital Acute Kidney Injury

ClinicalTrials.gov study NCT06697730. IPD Sharing: UNDECIDED. Countries: 0. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Study to Evaluate the Incidence of Gastric Ulcers Following Administration of Either PN 200 or Naproxen in Subjects Who Are at Risk for Developing NSAID-Associated Ulcers.

ClinicalTrials.gov study NCT00367211. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

The THINK Study Incidence of Neurotrophic Keratopathy)

ClinicalTrials.gov study NCT06482164. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Incidence of Hoarseness After General Spine Surgery: Prospective Observational Study

ClinicalTrials.gov study NCT05996146. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Effects of Different Doses of Intravenous Lidocaine Infusion on Peri-operative Pain and Incidence of Postoperative Chronic Pain Within ERAS Protocols, a Dose Finding Study.

ClinicalTrials.gov study NCT06431165. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Monocentric Observational Study: Postoperative Pain After Cesarean Section: Incidence and Risk Factors.

ClinicalTrials.gov study NCT04280432. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Non-COVID Patient-safety Incidents Reported by Primary Care Professionals in Time of Lockdown: Protocol for a Cross-sectional Descriptive Study

ClinicalTrials.gov study NCT04348552. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Incidence of Proximal Junctional Kyphosis (PJK) in Long Posterior Spinal Fusion: A Study Comparing Traditional Open Surgery to Minimally Invasive Percutaneous Technique at the Proximal Fusion Levels

ClinicalTrials.gov study NCT00890227. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

A Study Utilising Data From European Union (EU) National Multiple Sclerosis (MS) Registries to Assess the Incidence of Anti-Natalizumab Antibody Among Participants Who Receive Subcutaneous Administrat

ClinicalTrials.gov study NCT05925049. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

Cohort Study of HIV-1 Incidence Among Clients of the Thai Red Cross AIDS Research Center, Bangkok, Thailand

ClinicalTrials.gov study NCT00713531. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Comparison of Environmental Factors Between the Areas of Over- and Under-incidence of Crohn's Disease in the Haut de France Region, by the Study of Dental Exposomes

ClinicalTrials.gov study NCT03706196. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Does the Thickness of the Gastrostomy Affect the Incidence of Complications? A Prospective Randomized Single-Center Study in Children

ClinicalTrials.gov study NCT07300865. IPD Sharing: NO. Countries: 1. Publications: 0.

closedIPD-NOFeb 2026View details →
ClinicalTrials.gov24/100

Efficacy and Safety Study of Azimilide on the Incidence of Cardiovascular Hospitalizations/Emergency Department Visits or Cardiovascular Death in Patients With an Implantable Cardioverter Defibrillato

ClinicalTrials.gov study NCT01464476. IPD Sharing: Not stated. Countries: 13. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Observational Study for the Evaluation of Incidence of Familial AML/MDSs in Patients With Myeloid Neoplasms

ClinicalTrials.gov study NCT04460950. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Multifactorial Study of the Relationship Between the Conditions of Life and the Incidence of Risk of Falling

ClinicalTrials.gov study NCT04301713. IPD Sharing: YES. Countries: 1. Publications: 0.

controlledIPD-YESFeb 2026View details →
ClinicalTrials.gov24/100

An Observational Study to Register the Incidence of Breast Cancer and Current Clinical Care Patterns in Kenya

ClinicalTrials.gov study NCT01484483. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Study on the Incidence of Delirium in a Respiratory Weaning Centre

ClinicalTrials.gov study NCT00611377. IPD Sharing: Not stated. Countries: 1. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →
ClinicalTrials.gov24/100

Surveillance Study to Estimate the Incidence of Pure Red Blood Cell Aplasia Among Patients With Chronic Kidney Failure

ClinicalTrials.gov study NCT00391287. IPD Sharing: Not stated. Countries: 15. Publications: 0.

restrictedIPD-UNDECIDEDFeb 2026View details →

ScienceDex guides

Understand access before you commit

These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.

Compare curated datasets

Allen Brain Atlas

Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.

allen-brain-atlas
neuroscienceopenDocumentation, web resources, and API references are available online.
Last verified 2026-04-30Open record

Annotated Behaviour and Observability Dataset (ABODe)

ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.

abode-home-cage
behavioral-neuroscienceopenThe DataShare record exposes download links for annotations, documentation, license text, and the zipped per-snippet data directory.
Last verified 2026-04-30Open record

DANDI Archive for NWB datasets

DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.

dandi-nwb
electrophysiologyopenPublished Dandiset metadata and archive endpoints are available through the production DANDI API.
Last verified 2026-04-30Open record

International Brain Laboratory public data

The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.

ibl
behavioral-neuroscienceopenPublic sessions can be searched and loaded from the IBL public data server through ONE.
Last verified 2026-04-29Open record

OpenNeuro

OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.

openneuro
neuroscienceopenPublished datasets are available on demand over the internet.
Last verified 2026-04-29Open record